Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 2a (5-HT2a) receptor | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D4 | Starlite/ChEMBL | References |
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 417 aa | 20.6 % |
Onchocerca volvulus | Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog | Serotonin 2a (5-HT2a) receptor | 471 aa | 435 aa | 23.0 % |
Echinococcus granulosus | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 408 aa | 21.8 % |
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Serotonin 2a (5-HT2a) receptor | 471 aa | 405 aa | 25.4 % |
Echinococcus multilocularis | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 462 aa | 21.2 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Serotonin 2a (5-HT2a) receptor | 471 aa | 422 aa | 27.5 % |
Echinococcus granulosus | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 416 aa | 19.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0073 | 0.6723 | 1 |
Echinococcus granulosus | jun protein | 0.0089 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.007 | 0.6243 | 0.6243 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0089 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.952 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0 | 0.5 |
Onchocerca volvulus | 0.007 | 0.6243 | 0.5 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0089 | 1 | 1 |
Echinococcus multilocularis | jun protein | 0.0089 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0 | 0.5 |
Schistosoma mansoni | jun-related protein | 0.0073 | 0.6723 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 163 nm | In vitro binding affinity at human cloned Dopamine receptor D4 expressed in Sf9 cell membranes | ChEMBL. | 12408724 |
Ki (binding) | = 163 nm | In vitro binding affinity at human cloned Dopamine receptor D4 expressed in Sf9 cell membranes | ChEMBL. | 12408724 |
Ki (binding) | = 164 nm | In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane | ChEMBL. | 12408724 |
Ki (binding) | = 164 nm | In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane | ChEMBL. | 12408724 |
Ki (binding) | > 1000 nm | In vitro binding affinity at Alpha-1 adrenergic receptor in rat cortical tissues | ChEMBL. | 12408724 |
Ki (binding) | > 1000 nm | In vitro binding affinity at Alpha-1 adrenergic receptor in rat cortical tissues | ChEMBL. | 12408724 |
Ki (binding) | = 19117 nm | In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes | ChEMBL. | 12408724 |
Ki (binding) | = 19117 nm | In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes | ChEMBL. | 12408724 |
Ratio (binding) | = 1.44 | Binding affinity ratio against rat cortical tissue 5-HT2 versus human D2, calculated using pKi (-logKi) values | ChEMBL. | 12408724 |
Ratio (binding) | = 117 | Binding affinity ratio against human dopamine D2L versus D4.2, calculated using pKi (-logKi) values | ChEMBL. | 12408724 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.